4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-24-000097
CIK 0000875320other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:29 PM ET
Size
6.1 KB
Accession
0000875320-24-000097
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-02-23$431.79/sh−828$357,522→ 8,848 total - Sale
Common Stock
2024-02-26$425.70/sh−883$375,893→ 7,965 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:29 PM ET
- Size
- 6.1 KB